Home >> Industry News >> BD, BioGX announce FDA EUA for COVID-19 dx

BD, BioGX announce FDA EUA for COVID-19 dx

image_pdfCreate PDF

The test runs on the BD Max System, which can process 24 samples simultaneously. BD is working on an antigen test for its point-of-care BD Veritor System.

CAP TODAY
X